Exchange: NASDAQ·Updated 04:24 PM EDT
KPTI logo

KPTI Karyopharm Therapeutics Inc

$0.4756
$0.0286
(5.24%)
Today
Closed $0.5175
$0.0419
(8.10%)
After Hours
EarningsNov 3
Mkt Cap$12.39M
Vol1.96M

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.
79

Extremely Bullish Sentiment

How do you feel about KPTI?

Carnagex
$KPTI Today is the deadline for the forbearance. No announcement. Stock price up 51% in two days now without an announcement? Today is 3.6X normal average volume. Something is happening and someone knows something. This boost is not retail speculation on a distressed company staring at bankruptcy. This is a rocket ship that is on countdown. The people in the know are boarding ahead of time. 🚀👀
2
2
pblegend66
$KPTI the company market cap is less than $10 million. The company has annual revs of ~$130 million. If their sNDA gets accepted (this week or next week), the company will have a grip on a $1 billion/year revenue indication which they can start selling into as early as next quarter. This will rerate soon, and it will rerate fast. The odds of bankruptcy dramatically decreased with the forbearance extensions
7
ekpemofolo
$KPTI It is painful to watch the speculation on the stock price, but I see the extension very positive: bankruptcy can be ruled out. They might be waiting for FDA, but sNDA in itself does nothing to the cash situation. They likely have a deal pending on the FDA communication. Let's see whether there will be any leaks...
1
4
pblegend66
$KPTI the sell off was way overdone by an order of magnitude. It was because the fear on boards like this that bankruptcy was imminent. That wasn't true so now everyone is piling back in. It'll go back to a more fair value of a $100+ million market cap.
4
Dragonfly41
$KPTI Heavily shorted down to rock bottom Super short squeeze coming anyday Just $7 mil mktcap with 22 mil OS New sNDA indication bring on huge $1 billion annual revenue Real hidden diamond stock
6
pblegend66
$KPTI I'm also expecting one last forbearance extension. Likely filed tomorrow. This will give the company and their lenders time to restructure their loan/royalty agreements with the FDA acceptance in hand. In my opinion, if the lenders wanted to create a liquidity crunch to force bankruptcy, they had every chance to do it already. They didn't need to give KPTI a monthlong forbearance in September. And they certainly wouldn't have given them another extension last week. To me, this indicates they are working together to get to the FDA acceptance so they can restructure their previous deal. The hope is that the restructure will entail an increase in royalties, and not so much equity.
5
ekpemofolo
$KPTI I was staying away from Karyo for a long time. These are real hard times, because of immediate financing issues. But yesterday and today created a very attractive risk/reward situation. Not clear whether they will make it through the next weeks/months. But if they do, these days provide a great entry point. Big risk, but big reward. I am giving it a shot.
6
Carnagex
$KPTI I bought 25 more contracts Jan 2029 2.00 strike. Once the refinancing overhang clears then we are onto the science. Great entry imo. Time will tell.
1
3
Dragonfly41
$KPTI • Jefferies: Maintains a Buy rating, with the price target lowered to $11. • Piper Sandler: Maintains an Overweight rating, with the price target lowered to $7.
5
Dragonfly41
$KPTI The run just started and will keep going up until FDA acceptance news next week and real huge explosion upon the news Super explosion incoming
3
ekpemofolo
$KPTI They extended the deadline to October 22nd. A deal must be in the works. Otherwise there is no difference between declaring bk now or in a week.
5
Commenaudin36
$KPTI I just bought into KPTI at an average price of $0.67. This thing is a real gamble. You could lose everything, or you could see a 10x return. Do your research and you'll understand why. I'm taking the bet.
4
celebratelife
$KPTI RICHARD PAULSON, BARRY GREENE, GAREN BOHLIN... WASTED HUNDREDS OF MILLIONS IN INVESTOR MONEY ON THE FUCKING ENTITLED LAZY UNPRODUCTIVE VACATION-CLUB STYLE CULTURE AT SHAREHOLDER COST. THEY'VE NEVER GIVEN A SHIT ABOUT SHAREHOLDERS OR WASTING OUR MONEY AS LONG AS THEY GOT THEIR FUCKING BIG BUCKS DESPITE THEIR LOUSY PERFORMANCE. GREAT FOR INSIDERS, GREAT FOR SHORT SELLERS, GREAT FOR THEMSELVES AND THE REST OF THE LOUSY BOARD. DISASTER FOR SHAREHOLDERS. AND IT'S NOT LIKE HE DIDN'T KNOW. WE WARNED THEM TIME AND AGAIN BUT THEIR MIND WAS SOMEWHERE ELSE APPARENTLY -- NOT WHAT THEIR MANDATE CALLED FOR (TO DRIVE SHAREHOLDER VALUE) BUT TO MAXIMIZE THEIR OWN EXPERIENCE AT OUR COST. THAT'S HOW IT APPEARS. AND MEANWHILE SOME HEDGE FUNDS HAVE MADE HUNDREDS OF MILLIONS OF OUR MONEY.
1
1
Bigjohnson99
$KPTI careful with this trash. Some new pump tard has moved in, assuming it’s one of the 2 morons on X that actually are still bullish. Don’t buy this shit, it’s bankrupt.
3
Spanish_guy
$KPTI this wont go to BK cause créditors want their money. Probably they Will do a reverse Split and print more shares for them, dillution shareholders as hell.
3
Carnagex
$KPTI my assessment. Basically, the market is pricing in a bankruptcy. 13 million MC. Revenue is 10x greater then market cap. If it survives bankruptcy then the stock should rerate greatly. The problem now is that its creditors may force a bankruptcy and acquire a large ownership in the company thru a restructure effectively cutting out shareholders. A creditor could view 144m in revenue and the pipeline as more valuable after bankruptcy especially since they’d own a large share of the company. It’s a math issue whether company survival the debt payoff with interest and their holdings are of more value then forcing bankruptcy. I guess we will know soon.
3
celebratelife
$KPTI For years, the lousy, incompetent or compromised Richard Paulson/the Board of Directors led by Barry Greene that were supposed to control him, hurt the company financially in many ways including giving multi-six-figure donations and having lots of fun in celebrity photo shoots, and feeding their ugly faces with daily catered free lunches, and unnecessary travels, etc. etc. - everything good CEOs do NOT do. But they apparently never gave a shit about shareholders who hired them to create value. This picture shows they gave more money than Amgen! Hundreds of thousands of our money that they got by diluting us and toxic financing that paralyzed the company, with no fucking sense of ACCOUNTABILITY. And Paulson has the nerve after shit hit the fan to even utter the words "FINANCIAL DISCIPLINE".
3
Bigjohnson99
$KPTI tutes dumping the rest of their positions on morons chasing a bankrupt co!😂 Pump it right before the forbearance agreement expires and the co is forced into insolvency. Only retards are buying this trash.
2
Streetbullx2
$KPTI sold at 54, bought at 37, no need to risk gains. if it goes back yo 40 ill reenter. for the time being GLTA
1
celebratelife
$KPTI - 2k contracts (200k shares) of $.5 Feb puts traded at bid yesterday. OI up by exactly 2k contracts. Impossible to know exactly but on the face of it it was a seller opening which is bullish, but it's a disgrace to even talk about these prices when a $300+ stock has been killed down to 30 cents by factors that include mismanagement, excessive spending, wasting assets, no sense of responsibility or accountability on the part of CEO Richard Paulson and the lousy Board which has apparently failed its duties, and others -- all of whom have gotten huge sums of money as KPTI has been slaughtered, and they apparently kept wasting assets and running the company like a fucking charity. Now, no money left to get to key MF milestone, and the company has no leverage because it's knee deep in debt thanks to Richard Paulson, Mike Mason, Mike Mano, Lisa DiPaolo, Barry Greene and the rest of the clowns on the Board. Meanwhile shorts and toxic financiers have made big bucks at shareholder cost.
2

Advertisement|Remove ads.